TY - JOUR
T1 - Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis
AU - Rees, Elliott
AU - Carrera, Noa
AU - Morgan, Joanne
AU - Hambridge, Kirsty
AU - Escott-Price, Valentina
AU - Pocklington, Andrew J.
AU - Richards, Alexander L.
AU - Pardinas, Antonio F.
AU - McDonald, Colm
AU - Donohoe, Gary
AU - Morris, Derek W.
AU - Kenny, Elaine
AU - Kelleher, Eric
AU - Gill, Michael
AU - Corvin, Aiden
AU - Kirov, George
AU - Walters, James T. R.
AU - Holmans, Peter
AU - Owen, Michael J.
AU - O'Donovan, Michael C.
AU - Alizadeh, Behrooz Z.
AU - van Amelsvoort, Therese
AU - Bartels-Velthuis, Agna A.
AU - van Beveren, Nico J.
AU - Bruggeman, Richard
AU - Cahn, Wiepke
AU - de Haan, Lieuwe
AU - Delespaul, Philippe
AU - Meijer, Carin J.
AU - Myin-Germeys, Inez
AU - Kahn, Rene S.
AU - Schirmbeck, Frederike
AU - Simons, Claudia J. P.
AU - van Haren, Neeltje E.
AU - van Os, Jim
AU - van Winkel, Ruud
AU - Luykx, Jurjen J.
AU - Genetic Risk and Outcome of Psychosis (GROUP) Investigators
N1 - Funding Information:
Data governance was provided by the METADAC data access committee, funded by ESRC , Wellcome , and MRC . (Grant No. MR/N01104X/1 ). This work made use of data and samples generated by the 1958 Birth Cohort (NCDS), which is managed by the Centre for Longitudinal Studies at the UCL Institute of Education, funded by the Economic and Social Research Council (Grant No. ES/M001660/1 ). Access to these resources was enabled via the Wellcome Trust and Medical Research Council 58READIE Project (Grant Nos. WT095219MA and G1001799). Genotyping was undertaken as part of the Wellcome Trust Case Control Consortium under Wellcome Trust award 076113, and a full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk . Before 2015 biomedical resources were maintained under the Wellcome Trust and Medical Research Council 58READIE Project (Grant Nos. WT095219MA and G1001799). This work made use of data and samples generated by the 1958 Birth Cohort ( http://www2.le.ac.uk/projects/birthcohort , http://www.bristol.ac.uk/alspac/ , http://www.cls.ioe.ac.uk/ncds , http://www.esds.ac.uk/findingData/ncds.asp ) under Grant No. G0000934 from the Medical Research Council, and Grant No. 068545/Z/02 from the Wellcome Trust.
Funding Information:
The work at Cardiff University was supported by Medical Research Council Centre Grant No. MR/L010305/1 (to MJO) and Program Grant No. G0800509 (to MJO, MCO, JTRW, VE-P, PH, AJP), European Community Seventh Framework Programme Grant No. HEALTH-F2-2010-241909 (Project EU-GEI), and European Union Seventh Framework Programme for research, technological development, and demonstration Grant No. 279227 (CRESTAR Consortium).Data governance was provided by the METADAC data access committee, funded by ESRC, Wellcome, and MRC. (Grant No. MR/N01104X/1). This work made use of data and samples generated by the 1958 Birth Cohort (NCDS), which is managed by the Centre for Longitudinal Studies at the UCL Institute of Education, funded by the Economic and Social Research Council (Grant No. ES/M001660/1). Access to these resources was enabled via the Wellcome Trust and Medical Research Council 58READIE Project (Grant Nos. WT095219MA and G1001799). Genotyping was undertaken as part of the Wellcome Trust Case Control Consortium under Wellcome Trust award 076113, and a full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk. Before 2015 biomedical resources were maintained under the Wellcome Trust and Medical Research Council 58READIE Project (Grant Nos. WT095219MA and G1001799). This work made use of data and samples generated by the 1958 Birth Cohort (http://www2.le.ac.uk/projects/birthcohort, http://www.bristol.ac.uk/alspac/, http://www.cls.ioe.ac.uk/ncds, http://www.esds.ac.uk/findingData/ncds.asp) under Grant No. G0000934 from the Medical Research Council, and Grant No. 068545/Z/02 from the Wellcome Trust.The datasets used for the analysis described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000473.v2.p2. Samples used for data analysis were provided by the Swedish Cohort Collection supported by the NIMH Grant No. R01MH077139, the Sylvan C. Herman Foundation, the Stanley Medical Research Institute and The Swedish Research Council (Grant Nos. 2009-4959 and 2011-4659). Support for the exome sequencing was provided by the NIMH Grand Opportunity Grant No. RCMH089905, the Sylvan C. Herman Foundation, a grant from the Stanley Medical Research Institute and multiple gifts to the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard.
Funding Information:
The datasets used for the analysis described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000473.v2.p2. Samples used for data analysis were provided by the Swedish Cohort Collection supported by the NIMH Grant No. R01MH077139, the Sylvan C. Herman Foundation, the Stanley Medical Research Institute and The Swedish Research Council (Grant Nos. 2009-4959 and 2011-4659). Support for the exome sequencing was provided by the NIMH Grand Opportunity Grant No. RCMH089905, the Sylvan C. Herman Foundation, a grant from the Stanley Medical Research Institute and multiple gifts to the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard.
Funding Information:
The infrastructure for the GROUP study is funded through the Geestkracht programme of the Dutch Health Research Council (Zon-Mw, Grant No. 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord Holland Noord. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia psycho-medical center The Hague. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGZ Eindhoven en De Kempen, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh voor Geestelijke Gezondheid, Mondriaan, Virenze riagg, Zuyderland GGZ, MET ggz, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Utrecht: University Medical Center Utrecht and the mental health institutions Altrecht, GGZ Centraal and Delta.)
Funding Information:
This study makes use of data generated by the DECIPHER community. A full list of centres who contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from [email protected] . Funding for the project was provided by the Wellcome Trust. Those who carried out the original DECIPHER analysis and collection of the Data bear no responsibility for the further analysis or interpretation of it by the Recipient or its Registered Users.
Funding Information:
The datasets used for the analysis described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000473.v2.p2. Samples used for data analysis were provided by the Swedish Cohort Collection supported by the NIMH Grant No. R01MH077139 , the Sylvan C. Herman Foundation , the Stanley Medical Research Institute and The Swedish Research Council (Grant Nos. 2009-4959 and 2011-4659 ). Support for the exome sequencing was provided by the NIMH Grand Opportunity Grant No. RCMH089905 , the Sylvan C. Herman Foundation, a grant from the Stanley Medical Research Institute and multiple gifts to the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard.
Funding Information:
The work at Cardiff University was supported by Medical Research Council Centre Grant No. MR/L010305/1 (to MJO) and Program Grant No. G0800509 (to MJO, MCO, JTRW, VE-P, PH, AJP), European Community Seventh Framework Programme Grant No. HEALTH-F2-2010-241909 (Project EU-GEI), and European Union Seventh Framework Programme for research, technological development, and demonstration Grant No. 279227 (CRESTAR Consortium).
Publisher Copyright:
© 2018 Society of Biological Psychiatry
PY - 2019/4/1
Y1 - 2019/4/1
N2 - BACKGROUND: Sequencing studies have pointed to the involvement in schizophrenia of rare coding variants in neuronally expressed genes, including activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-D-aspartate receptor (NMDAR) complexes; however, larger samples are required to reveal novel genes and specific biological mechanisms.METHODS: We sequenced 187 genes, selected for prior evidence of association with schizophrenia, in a new dataset of 5207 cases and 4991 controls. Included among these genes were members of ARC and NMDAR postsynaptic protein complexes, as well as voltage-gated sodium and calcium channels. We performed a rare variant meta-analysis with published sequencing data for a total of 11,319 cases, 15,854 controls, and 1136 trios.RESULTS: While no individual gene was significantly associated with schizophrenia after genome-wide correction for multiple testing, we strengthen the evidence that rare exonic variants in the ARC (p = 4.0 x 10(-4)) and NMDAR (p = 1.7 x 10(-5)) synaptic complexes are risk factors for schizophrenia. In addition, we found that loss-of-function variants and missense variants at paralog-conserved sites were enriched in voltage-gated sodium channels, particularly the alpha subunits (p = 8.6 x 10(-4)).CONCLUSIONS: In one of the largest sequencing studies of schizophrenia to date, we provide novel evidence that multiple voltage-gated sodium channels are involved in schizophrenia pathogenesis and confirm the involvement of ARC and NMDAR postsynaptic complexes.
AB - BACKGROUND: Sequencing studies have pointed to the involvement in schizophrenia of rare coding variants in neuronally expressed genes, including activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-D-aspartate receptor (NMDAR) complexes; however, larger samples are required to reveal novel genes and specific biological mechanisms.METHODS: We sequenced 187 genes, selected for prior evidence of association with schizophrenia, in a new dataset of 5207 cases and 4991 controls. Included among these genes were members of ARC and NMDAR postsynaptic protein complexes, as well as voltage-gated sodium and calcium channels. We performed a rare variant meta-analysis with published sequencing data for a total of 11,319 cases, 15,854 controls, and 1136 trios.RESULTS: While no individual gene was significantly associated with schizophrenia after genome-wide correction for multiple testing, we strengthen the evidence that rare exonic variants in the ARC (p = 4.0 x 10(-4)) and NMDAR (p = 1.7 x 10(-5)) synaptic complexes are risk factors for schizophrenia. In addition, we found that loss-of-function variants and missense variants at paralog-conserved sites were enriched in voltage-gated sodium channels, particularly the alpha subunits (p = 8.6 x 10(-4)).CONCLUSIONS: In one of the largest sequencing studies of schizophrenia to date, we provide novel evidence that multiple voltage-gated sodium channels are involved in schizophrenia pathogenesis and confirm the involvement of ARC and NMDAR postsynaptic complexes.
KW - ARC
KW - BURDEN
KW - DE-NOVO MUTATIONS
KW - DISORDERS
KW - FRAMEWORK
KW - GENOME-WIDE ASSOCIATION
KW - Genetics
KW - INDIVIDUALS
KW - NMDAR
KW - OF-FUNCTION VARIANTS
KW - RISK
KW - SETD1A
KW - SUSCEPTIBILITY
KW - Schizophrenia
KW - Sequencing
KW - Voltage-gated sodium channels
U2 - 10.1016/j.biopsych.2018.08.022
DO - 10.1016/j.biopsych.2018.08.022
M3 - Article
C2 - 30420267
SN - 0006-3223
VL - 85
SP - 554
EP - 562
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 7
ER -